The Data Revolution: Personalized Medicine and the Future of Healthcare
The following is a guest article by Dr. Waqaas Al-Siddiq, Chairman, CEO & Founder at Biotricity. In 2011, near the end of his almost decade-long fight with cancer, Steve Jobs had a realization: “I...
View ArticleBioethics Conference Poses Twenty-First Century Questions
The Center for Bioethics at Harvard Medical School recently held an online conference covering the current state of the field. All the standard ethical issues we talk about in medicine appear in the...
View ArticleWhat’s Required for an Enterprise Vision for Precision Medicine?
At the recent HIMSS 2021 conference in Las Vegas, I had a chance to sit down with Dr. Joel Diamond, Chief Medical Officer at 2bPrecise and Dr. Maulik Purohit, Chief Innovation Lead and Associate Chief...
View ArticleAccessDX Holdings Acquires 2bPrecise
Combined capabilities create industry’s most advanced precision medicine enablement solution AccessDX Holdings, an international provider of advanced laboratory diagnostic solutions, has acquired...
View Article23andMe Agrees to Acquire Lemonaid Health
Acquisition provides telemedicine platform for 23andMe to advance its vision of individualized primary care that empowers consumers to live healthier lives 23andMe Holding Co. (Nasdaq: ME) (“23andMe”),...
View ArticleTechnology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners, and Pitango HealthTech Variantyx, a technology-driven...
View ArticleCancerIQ Raises $14M Series B Funding to Improve Access to Innovations in...
CancerIQ, the platform powering early cancer detection and prevention across broad patient populations, announced today it closed a $14 million Series B financing round co-led by Merck Global Health...
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View ArticleOnc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action...
Financing will support commercialization of a novel digital clinical management solution focused on immuno-oncology therapies Onc.AI, a medical technology company developing a novel digital clinical...
View ArticlePreventing Genetic Testing Fraud: 5 Actions for Health Plans
The following is a guest article by Erin Rutzler, Vice President of Fraud, Waste, and Abuse at Cotiviti In Delaware, more than 250 Medicare patients underwent unnecessary genetic testing based on...
View Article